The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer
Open Access
- 1 August 1993
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 3 (5) , 285-292
- https://doi.org/10.1046/j.1525-1438.1993.03050285.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancerBritish Journal of Cancer, 1992
- Prognostic value of CA 125 in advanced ovarian cancerGynecologic Oncology, 1992
- Savings obtained by CA-125 measurements during therapy for ovarian carcinomaEuropean Journal Of Cancer, 1992
- Categorising continuous variablesBritish Journal of Cancer, 1991
- CA-125 in ovarian cancer: Relation between half-life, doubling time and survivalEuropean Journal of Cancer and Clinical Oncology, 1991
- Early serum CA125 response and outcome in epithelial ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapyGynecologic Oncology, 1988
- CA125 as a serum marker for poor prognosis in ovarian malignanciesGynecologic Oncology, 1987
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983